MMP14 and cancer: In addition, MT1-MMP overexpression in some cancers makes this protein a selective target for bicyclic radiolabeled peptides, including DOTA-modified BCY molecules that have been approved in mouse xenograft models, using PET (positron emission tomography) imaging [134].